Korean J Gastroenterol.  2014 Feb;63(2):63-65. 10.4166/kjg.2014.63.2.63.

Decreased Eradication Rates of Helicobacter pylori and Problem Solving

• Jo Y

• KMID: 1730912
• DOI: http://doi.org/10.4166/kjg.2014.63.2.63

Abstract

No abstract available.

MeSH Terms

Anti-Bacterial Agents/*therapeutic use
Disease Eradication/*trends
Female
Helicobacter Infections/*drug therapy
*Helicobacter pylori
Humans
Male
Proton Pump Inhibitors/*therapeutic use
Anti-Bacterial Agents
Proton Pump Inhibitors

Reference

References

1. Kim SG, Jung HK, Lee HL, et al. Korean College of Helicobacter and Upper Gastrointestinal Research. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol. 2013; 62:3–26.

2. Choi YS, Cheon JH, Lee JY, et al. The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years. Korean J Gastroenterol. 2006; 48:156–161.

3. Na HS, Hong SJ, Yoon HJ, et al. Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and re-infection rate after successful eradication. Korean J Gastroenterol. 2007; 50:170–175.

4. Cho HJ, Bae RC, Lee SH, et al. The trend in the eradication rates of first- and second-line therapy for Helicobacter pylori infection in Daegu and Kyungpook provinces: a single center experience for the most recent 9 years. Korean J Med. 2009; 76:186–192.

5. Cho DK, Park SY, Kee WJ, et al. The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy. Korean J Gastroenterol. 2010; 55:368–375.

6. Chung JW, Lee GH, Han JH, et al. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepatogastroenterology. 2011; 58:246–250.

7. Yoon JH, Baik GH, Sohn KM, et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol. 2012; 18:6628–6634.

8. Jung YS, Lee SH, Park CS, et al. Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk- do, Korea: multicenter study over 13 years. Korean J Gastroenterol. 2014; 63:82–89.

9. Sasaki H, Nagahara A, Hojo M, et al. Ten-year trend of the cumulative Helicobacter pylori eradication rate for the ‘Japanese eradication strategy’. Digestion. 2013; 88:272–278.

10. Ang TL, Wang L, Ang D, Chiam P, Fock KM, Teo EK. Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis. J Dig Dis. 2013; 14:100–104.

11. Lee JW, Kim N, Kim JM, et al. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter. 2013; 18:206–214.

12. Byun YH, Jo YJ, Kim SC, et al. Clinical factors that predicts successful eradication of Helicobacter pylori. Korean J Gastroenterol. 2006; 48:172–179.

13. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010; 59:1143–1153.

14. Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013; 12:CD008337.